MAGGI, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 1.546
NA - Nord America 1.151
EU - Europa 371
SA - Sud America 253
AF - Africa 71
OC - Oceania 6
Totale 3.398
Nazione #
US - Stati Uniti d'America 1.061
SG - Singapore 463
CN - Cina 440
VN - Vietnam 211
BR - Brasile 148
IT - Italia 113
HK - Hong Kong 100
FR - Francia 65
DE - Germania 55
IN - India 53
BD - Bangladesh 45
AR - Argentina 42
MX - Messico 35
ID - Indonesia 33
TR - Turchia 33
GB - Regno Unito 26
IQ - Iraq 26
PK - Pakistan 24
ZA - Sudafrica 22
PH - Filippine 21
SA - Arabia Saudita 20
PL - Polonia 18
CA - Canada 17
ES - Italia 17
MY - Malesia 17
VE - Venezuela 16
FI - Finlandia 15
EC - Ecuador 13
JM - Giamaica 12
RU - Federazione Russa 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
UA - Ucraina 10
DZ - Algeria 9
MA - Marocco 9
CR - Costa Rica 8
JP - Giappone 8
NL - Olanda 8
CO - Colombia 7
UY - Uruguay 6
AU - Australia 5
JO - Giordania 5
PY - Paraguay 5
TN - Tunisia 5
AL - Albania 4
PE - Perù 4
RO - Romania 4
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
LY - Libia 3
NI - Nicaragua 3
NP - Nepal 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
TW - Taiwan 3
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
KH - Cambogia 2
LB - Libano 2
MR - Mauritania 2
MV - Maldive 2
QA - Qatar 2
SE - Svezia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CD - Congo 1
CG - Congo 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
Totale 3.386
Città #
San Jose 347
Singapore 141
Hong Kong 97
New York 76
Beijing 66
Ho Chi Minh City 63
Hanoi 51
Hillsboro 25
Ashburn 17
Council Bluffs 17
Milan 17
Warsaw 16
São Paulo 14
Da Nang 13
Helsinki 13
Haiphong 11
Istanbul 11
Nuremberg 11
Reston 11
Baghdad 10
Johannesburg 10
Rockville 10
Kuala Lumpur 9
Rome 9
Frankfurt am Main 8
Mexico City 8
Birmingham 7
Bologna 7
Jakarta 7
Los Angeles 7
Santa Clara 7
Caracas 6
Jeddah 6
Kingston 6
Lahore 6
Limburg an der Lahn 6
Belo Horizonte 5
Bend 5
Buffalo 5
Cape Town 5
Orem 5
Quito 5
Tokyo 5
Algiers 4
Amman 4
Brasília 4
Campinas 4
Dammam 4
Go Vap 4
Hai Bà Trưng 4
Karachi 4
Lanús 4
Montevideo 4
Naples 4
Pune 4
Quận Ba 4
Riyadh 4
San José 4
Santiago 4
Toronto 4
Turin 4
Zhengzhou 4
Addis Ababa 3
Amsterdam 3
Ankara 3
Bhopal 3
Bragança Paulista 3
Can Tho 3
Casablanca 3
Catacocha 3
Chandigarh 3
Cuauhtémoc 3
Curitiba 3
Dakar 3
Dallas 3
Erbil 3
Guadalajara 3
Guayaquil 3
Hyderabad 3
Kuching 3
Lima 3
Managua 3
Manassas 3
Maracaibo 3
Medina 3
Multan 3
Nairobi 3
Najaf 3
New Delhi 3
Nha Trang 3
Nottingham 3
Palermo 3
Petaling Jaya 3
Porto Alegre 3
Rio de Janeiro 3
San Pedro Sula 3
San Salvador 3
Sharjah 3
Surabaya 3
Surat 3
Totale 1.371
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 50
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 43
. Long term non progressors among IVDA: behavioural, clinical and virological aspects 18
Leishmaniosi viscerale in Puglia: indagine policentrica conoscitiva 18
In vitro modulation of adipocyte differentiation by tenofovir alafenamide/disoproxil fumarate following challenge with recent ARV drugs 18
A color-doppler ultrasonographic comparative study between patients treated with PI-including regimens vs NNRTI-including regimens (Prevaleat study) 17
RADAR Study Group of the Master Cohort. Lopinavir plasma levels in salvage regimes by a population of highly active antiretroviral therapy-treated HIV-1-positive patients 16
Reazioni nel sito di iniezione in pazienti trattati a lungo termine con enfuvirtide 16
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 16
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient 16
Behavioural, clinical and virological aspects in a cohort of Long Term non Progressors 16
Parkinsonism in a patient with AIDS and cerebral opportunistic granulomatous lesions 16
Factors associated with hospital admission for COVID-19 in HIV patients 15
Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer inhibitor-based regimen in Italy: findings from the NEURO-INSTI study 15
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 15
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 15
La percezione della malattia renale nelle persone con infezione da HIV: un approccio di medicina narrativa 15
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 15
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics) 15
Intestinal microsporidiosis in AIDS patients with diarrhoeal illness in Apulia (South Italy) 14
Su due casi di Leishmania-HIV osservati in Puglia 14
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation 14
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 14
The Less Drugs Regimens (LDRs) therapy approach in HIV-1: an Italian expert panel perspective for the long-term management of HIV-1 infection 14
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 14
A nodular pulmonary lesion due to Linguatula serrata in an HV-positive man 14
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 14
Accettabilità del condom: studio su una coorte di tossicodipendenti e loro partners 14
A case of human brucellosis caused by accidental injection of animal vaccine 14
Tossicità a lungo termine delle terapie antiretrovirali 14
Studi di prevalenza dell'infezione da HIV in pazienti ospedalizzati 14
La gestione del rischio cardiovascolare nel paziente HIV-positivo 14
Long-term administration of Inosine-Pranobex (INPX) in anti-HIV asymptomatic carriers. Preliminary results of a controlled study 14
B-mode Ultrasound Study of Carotid Plaques in HIV-positive Patients to Detect the Presence of Inflammatory Endothelial Lesions 14
A color doppler ultrasound-based comparative study between stavudine and non-stavudine regimens in the onset of vascular lesions in HIV-1 positive patients 14
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 13
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 13
National multicentric study on maintenance therapy for CMV disease in AIDS patients 13
Nontyphoidal salmonellosis in AIDS: epidemiological and clinical features in South-Eastern Italy 13
A Cyanobacterium-Like Body found in the stools of an HIV+ patient with diarrhoea 13
Modificazioni dell'intima-media carotidea, attivazione endoteliale e marker di infiammazione in pazienti HIV-positivi naive avanzati che iniziano terapia antiretrovirale: studio PREVALEAT II. Rapporto in itinere 13
Occupational risk for HIV infection among non-healt care workers 13
Hyperhomocysteinemia: in HIV-1 positive patients: the role of antiretroviral therapy 13
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 13
Il ruolo dell'immunoricostituzione nell'insorgenza di lesioni ateromasiche subcliniche. XXII Congresso Nazionale AIDS e sindromi correlate. Palermo 6-7/11/2008. Abstract book pag 104 13
Co-infezione polmonare da Chlamydia trachomatis e Mycobacterium tuberculosis 13
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort 13
The Role of Immune Dysregulation Markers in Cardiovascular Risk of People Living with HIV: Association Among Intima Media Changes, CD4/CD8 Ratio, and CD4+ Cell Count Nadir 13
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 13
Citrati urinari ed escrezione di glucosaminoglicani in soggetti sani ed in pazienti con nefrolitiasi ossalocalcica recidivante 13
Lipids and Body Mass Index in Antiretroviral‐Experienced People With HIV on Doravirine‐Based Treatments: A Comparison Between Dual or Triple Regimen Versus Bictegravir‐Based Triple Regimen 12
Implications of AB0 blood group in hypertensive patients with covid-19 12
GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial 12
Leptospirosi in cavalli importati dall'Europa dell'Est: una nuova potenziale fonte di infezione umana in Puglia 12
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 12
Utilizzo della definizione di Sindrome metabolica e del Framingham risk score per identificare pazienti naive a maggior rischio cardiovascolare. Risultato dello studio multicentrico HERMES 12
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 12
A greater prevalence of X4 viruses in HIV type 1 intravenous drug users reflects a "CD4+ effect" 12
Role of chlamydia infection in the pathogenesis of atherosclerotic plaques in HIV-1-positive patients 12
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 12
Cyclospora-like bodies in AIDS patients 12
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 12
Infezioni da anaerobi 12
The problem of renal function monitoring in patients treated with the novel antiretroviral drugs 12
L'infezione sifilitica nei pazienti HIV-positivi: studio su una coorte di 707 soggetti 12
Trasmissione dell'infezione da HIV in coppie stabili discordanti: aspetti comportamentali, clinici e prognostici 12
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 12
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study 12
Atherosclerosis in HIV patients: a new face for an old disease? 12
More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study 12
Prevalenza di criptosporidiosi in pazienti HIV-positivi con sindrome diarroica 12
Dolutegravir safety in a real-life setting: results Title from the SCOLTA cohort 12
A comprehensive development agenda on tenofovir alafenamide in clinical practice 12
Sindromi extrapiramidali da toxoplasmosi cerebrale in pazienti con AIDS 12
Question and answers on long-acting therapy with cabotegravir and rilpivirine in people with HIV 12
Cyanobacterium-Like Bodies in stools of a HIV + patient with diarrhoea 12
Cardiovascular risk in advanced naive HIV-infected atients starting antiretroviral therapy: comparison of three different regimens based on ATV, DRV or EFV – PREVALEAT II (Premature Vascular Lesions and Antiretroviral Therapy II) Cohort 12
. First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006) 12
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 12
Effect of antiretroviral therapy on cryptosporidiosis and microsporidiosis in patients infected with Human Immunodeficiency Virus type 1 11
Rischio di lesioni cardiovascolari in pazienti sieropositivi in trattamento antiretrovirale 11
Decreasing cardiovascular risk in HIV infection between 2005 and 2011 11
Aumentata incidenza di epatiti NANB non correlate a trasfusioni in pazienti emodializzati 11
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: a cross-sectional study 11
Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) 11
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 11
Il colera 11
Insufficienza renale acuta da rabdomiolisi (caso clinico) 11
Pillars of long-term antiretroviral therapy success 11
Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors 11
Assessment of biological risk of blood transmission among health workers at a Bari university hospital 11
Cyclospora in AIDS patients: not always an agent of diarrhoic syndrome 11
Interazioni farmacologiche nei pazienti in trattamento con antiretrovirali 11
Risk of Cardiovascular Events in People with HIV (PWH) Treated with Integrase Strand-Transfer Inhibitors: The Debate Is Not Over; Results of the SCOLTA Study 11
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 11
Primary prophylaxis against pneumocystis carinii and Toxoplasma gondii with low dose cotrimoxazole: a case-control study 11
Novel Antiretroviral Drugs and Renal Function Monitoring of HIV Patients. 11
HBV positivity seroprevalence in 355 subjects accidentally esposed to needlesticks from abandoned syringes 11
Prevalence, Awareness, Treatment, and Control Rate of Hypertension in HIV-Infected Patients: The HIV-HY Study 11
AIDS e protozoi intestinali in Puglia 11
Totale 1.363
Categoria #
all - tutte 7.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/20263.837 0 0 0 0 22 19 1 2.063 1.039 693 0 0
Totale 3.837